EULAR 2024 | EULAR Abstract Awards
EULAR bestows Abstract Awards to the first authors of abstracts submitted to the EULAR Annual European Congress . Winners are selected by the EULAR Scientific Program Committee based on the quality of the abstracts' scientific content. The award ceremony takes place at the EULAR Annual European Congress' Opening plenary session.
Abstract Award – Basic science
EULAR bestows 6 Abstract Awards to the presenting authors of basic science abstracts that are submitted to the EULAR Annual European Congress. Winners are selected by the EULAR Scientific Program Committee based on the quality of the abstracts' scientific content.
No special application is required for this award.
Abstract Award – Clinical science
EULAR bestows 6 Abstract Awards to the presenting authors of clinical science abstracts that are submitted to the EULAR Annual European Congress. Winners are selected by the EULAR Scientific Program Committee based on the quality of the abstracts' scientific content.
No special application is required for this award.
Health Professionals Abstract Award
EULAR grants 3 Abstract Awards for submitted abstracts by Health Professionals as presenting authors. Winners are selected by the EULAR Scientific Program Committee based on the quality of the abstracts' content.
No special application is required for this award.
PARE Abstract Award
One award is given to the highest scored abstract submitted in the PARE category by a PARE representative or a patient. No special application is required for this award.
Undergraduate Abstract Award
Undergraduates are medical students who performed the studies during their medical education / training; they have not yet qualified as a physician and are in general below the age of 25 years. EULAR bestows 3 Abstract Awards to the presenting authors of the highest scored abstracts in basic science or clinical abstracts that are submitted to the EULAR Annual European Congress. Winners are selected by the EULAR Scientific Program Committee based on the quality of the abstracts' scientific content.
PLEASE NOTE: PhD students do not qualify! "Undergraduate" means being still in medical school and not having passed the final medical school examination yet.
Winners of EULAR Awards 2024
-
Dr. Sebvastian Viatte, United Kingdom
OP0111 Quiescent human blood monocyte states are pre-committed to an inflammatory synovial transcriptional program.
Abstract archive -
Dr. med. Corrado Campochiaro , Italy
OP0073 Unraveling pathophysiology and hematopoiesis of VEXAS syndrome by multi-omics analysis and targeted gene editing
Abstract archive -
Dr. Simone Perniola, Italy
OP0062 Multi-modal analysis of synovial tissue macrophages informs on treatment response in naive to treatment Rheumatoid Arthritis
Abstract archive -
Dr. Richard C. Bethell, Denmark
OP0210 Targeted degradation of Stimulator of Interferon Genes (STING) inhibits the elevated endogenous expression of inflammatory genes in fibroblasts from patients with Aicardi-Goutiéres syndrome (AGS) and STING-associated vasculopathy with onset in infancy (SAVI)
Abstract archive -
MD Shinji Izuka, Japan
OP0106 Roles of JAK-STAT signaling and GM-CSF for the development of osteitis and bone microstructure changes in rheumatoid arthritis
Abstract archive -
Dr. Kerstin Dürholz, Germany
OP0029 Gut-specific H3R signaling orchestrates microglia-dependent resolution of peripheral inflammation
Abstract archive
-
MD, PhD Blaž Burja, Switzerland
OP0013 Anti-Ro/SSA antibodies are predictive of a more severe lung involvement in patients with systemic sclerosis: a study from the EUSTAR database
Abstract archive -
Ms. Anusha Moses, Netherlands
OP0116 Treat to Target in gout yields superior outcomes compared to Treat to Avoid Symptoms approach (results from Gout TrEatment Strategy (GO TEST) OVERTURE trial) Glucocorticoids
Abstract archive -
MD, PhD Liubov Petelytska, Ukraine
OP0019 INCIDENCE AND RISK FACTORS FOR NEW ONSET INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS: INSIGHTS FROM AN ANALYSIS OF THE EUSTAR COHORT
Abstract archive -
Dr. Natalie McCormick, United States
OP0051 Prediagnostic proteomics of gout: prospective cohort study of 48,898 men and women
Abstract archive -
Mr. Nils Steinz, Netherlands
OP0018 Dissecting early RA patient trajectories through time-independent disease state identification identifies distinct patterns dissected by inflammation in blood or joints
Abstract archive
-
Ms. Zoe Clark, United Kingdom
OP0333-PARE Online patient education for axial spondyloarthritis self-management
abstract archive
-
Ms. Maria Hanif, United Kingdom
OP0246 Factors associated with injury accrual in Childhood Systemic Lupus Erythematosus (cSLE): corticosteroid regimens and maintenance of low disease activity
Abstract archive -
Ms. Yuan Zhao, China
OP0258 Performance Validation of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria in an Antiphospholipid Syndrome Cohort
Abstract archive - Mr. Sohma Wakasugi, Japan
OP0071 ICX3CR1-positive cytotoxic T cells specifically contribute to the pathogenesis of elderly-onset and difficult-to-treat rheumatoid arthritis
Abstract archive
-
Dr. Gitta Jacob, Germany
OP0097-HPR A cognitive behavioral digital health application is effective in improving psychological quality of life in patients with rheumatoid arthritis
Abstract archive -
Mr. Jesper Walther Larsen, Denmark
OP0235-HPR Comparing a Nurse-Led Treat-to-Target Urate-Lowering Strategy with Usual Care for Gout Patients: A Prospective Cohort Study
Abstract archive - Ms. M.A.T. van Wissen, Netherlands
OP0143-HPR Effectiveness of longstanding exercise therapy versus usual care in people with axial spondyloarthritis and severe functional limitations: a randomized controlled trial (L-EXSPA)
Abstract archive
-
Clinical Science Abstract awarded by FOREUM
Dr. PhD Stefania Croci, Italy
OP0014 Transcripts expressed in temporal artery biopsies associated with response to therapy in patients with giant cell arteritis
Abstract archive -
- Basic and Translational Science Abstract awarded by FOREUM
MD Edoardo Cipolletta, United Kingdom
OP0136 Risk of cardiovascular events in patients with gout starting urate-lowering therapy with or without flare prophylaxis with colchicine: an emulated target trial using English primary-care, hospitalization, and mortality data
Abstract archive - POS0001 Risk of cardiovascular events after first gout flare consultation in primary care: a self-controlled case series analysis using UK primary care, hospitalization, and mortality data
Abstract archive
